Prevalence of anthelmintic resistance on sheep farms in New Zealand

N Z Vet J. 2006 Dec;54(6):271-7. doi: 10.1080/00480169.2006.36710.

Abstract

Aim: To establish the prevalence of anthelmintic resistance in parasitic nematodes on sheep farms in New Zealand.

Methods: A cross-sectional prevalence study was conducted, using a standardised faecal nematode egg count (FEC) reduction (FECR) test (FECRT) for ivermectin, at a full (0.2 mg/kg) and half (0.1 mg/kg) dose rate, and albendazole, levamisole and albendazole-levamisole in combination, on 60 lambs (n=10 per group) on farms selected from throughout New Zealand. Farms that conformed with selection criteria were chosen at random (n=80) or with a history of suspected resistance to macrocyclic lactone (ML) anthelmintics (n=32). Resistance to an anthelmintic was inferred when there was <95% reduction in FEC 7-10 days after treatment. Larval cultures were performed for all control groups and for treated groups for which resistance was evident.

Results: Of the farms randomly selected, 36% showed > or =95% FECR for all anthelmintics tested; resistance to ivermectin at 0.1 and 0.2 mg/kg liveweight was evident on 36% and 25% of these farms, respectively. Resistance to both ivermectin (0.2 mg/kg) and levamisole was evident on 8/80 (10%) farms, to ivermectin and albendazole on 10/80 (13%) farms, and to ivermectin, levamisole and albendazole on 6/80 (8%) farms. The prevalence of resistance to a half dose of ivermectin tended to be more prevalent on farms with a history of suspected ML resistance (p=0.06). Resistance to albendazole was seen across all the main parasite genera, and to levamisole in Nematodirus, Ostertagia (= Teladorsagia) and Trichostrongylus species. Resistance to ivermectin was dominated by Ostertagia spp, although Cooperia, Nematodirus and Trichostrongylus species were also implicated.

Conclusion: Anthelmintic resistance in parasitic nematodes of sheep is common in New Zealand. Not only was resistance to albendazole and levamisole common, but resistance to the ML, ivermectin, was at a higher prevalence than expected. Sheep farmers and advisors in New Zealand need to re-evaluate the way they manage parasites, and more research is urgently needed if the steady decline in anthelmintic susceptibility is to be halted.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anthelmintics / pharmacology*
  • Anthelmintics / therapeutic use
  • Antinematodal Agents / pharmacology
  • Antinematodal Agents / therapeutic use
  • Cross-Sectional Studies
  • Drug Resistance*
  • Feces / parasitology
  • Female
  • Helminthiasis, Animal / drug therapy*
  • Helminthiasis, Animal / epidemiology
  • Helminthiasis, Animal / parasitology
  • Helminths / drug effects
  • Ivermectin
  • Male
  • Nematode Infections / drug therapy
  • Nematode Infections / epidemiology
  • Nematode Infections / parasitology
  • Nematode Infections / veterinary
  • New Zealand / epidemiology
  • Ostertagia / drug effects
  • Parasite Egg Count / veterinary
  • Parasitic Sensitivity Tests / veterinary
  • Prevalence
  • Sheep
  • Sheep Diseases / drug therapy*
  • Sheep Diseases / epidemiology
  • Sheep Diseases / parasitology
  • Treatment Outcome

Substances

  • Anthelmintics
  • Antinematodal Agents
  • Ivermectin